NORTHSEA THERAPEUTICS USA, INC.
Share on:
| Name: | NORTHSEA THERAPEUTICS USA, INC. |
| Jurisdiction: | New York |
| Legal type: | FOREIGN BUSINESS CORPORATION |
| Status: | Active |
| Date of registration: | 01 Nov 2022 (3 years ago) |
| Entity Number: | 6633119 |
| ZIP code: | 10005 |
| County: | New York |
| Place of Formation: | Delaware |
| Foreign Legal Name: | NORTHSEA THERAPEUTICS USA, INC. |
| Address: | 28 LIBERTY STREET, NEW YORK, NY, United States, 10005 |
| Principal Address: | 100 Northern Avenue, c/o Goodwin Procter LLP, Boston, MA, United States, 02210 |
| Name | Role | Address |
|---|---|---|
| ROB DE REE | Chief Executive Officer | 100 NORTHERN AVENUE, C/O GOODWIN PROCTER LLP, BOSTON, MA, United States, 02210 |
| Name | Role | Address |
|---|---|---|
| C T CORPORATION SYSTEM | DOS Process Agent | 28 LIBERTY STREET, NEW YORK, NY, United States, 10005 |
| Start date | End date | Type | Value |
|---|---|---|---|
| 2025-06-17 | 2025-06-17 | Address | 100 NORTHERN AVENUE, C/O GOODWIN PROCTER LLP, BOSTON, MA, 02210, USA (Type of address: Chief Executive Officer) |
| 2025-06-17 | 2025-06-17 | Address | 200 CLARENDON STREET, 22ND FLOOR, C/O FORBIION, BOSTON, MA, 02116, USA (Type of address: Chief Executive Officer) |
| 2024-11-26 | 2025-06-17 | Address | 100 NORTHERN AVENUE, C/O GOODWIN PROCTER LLP, BOSTON, MA, 02210, USA (Type of address: Chief Executive Officer) |
| 2024-11-26 | 2025-06-17 | Address | 28 LIBERTY STREET, NEW YORK, NY, 10005, USA (Type of address: Service of Process) |
| 2022-11-02 | 2024-11-26 | Address | 28 LIBERTY STREET, NEW YORK, NY, 10005, USA (Type of address: Service of Process) |
| Filing Number | Date Filed | Type | Effective Date |
|---|---|---|---|
| 250617001472 | 2025-06-11 | AMENDMENT TO BIENNIAL STATEMENT | 2025-06-11 |
| 241126001962 | 2024-11-26 | BIENNIAL STATEMENT | 2024-11-26 |
| 221102001230 | 2022-11-01 | APPLICATION OF AUTHORITY | 2022-11-01 |
This company hasn't received any reviews.
Date of last update: 21 Mar 2025
Sources: New York Secretary of State